Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression

It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chikh, Anissa, Ferro, Riccardo, Abbott, Jonathan J., Piñeiro, Roberto, Buus, Richard, Iezzi, Manuela, Ricci, Francesca, Bergamaschi, Daniele, Ostano, Paola, Chiorino, Giovanna, Lattanzio, Rossano, Broggini, Massimo, Piantelli, Mauro, Maffucci, Tania, Falasca, Marco
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4951291/
https://ncbi.nlm.nih.gov/pubmed/26934321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7761
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars